Cosmetic Implants Market is expected to grow significantly between 2022-2032

The global Cosmetic Implants Market is estimated to garner US$ 17.9 Billion while exhibiting a 5.8% CAGR during the forecast period. The growing support from several governments is likely to fuel the market growth in the coming years. The industry is expected to secure US$ 10.2 Billion in 2022.

Increasing expenditure on healthcare, growing awareness about cosmetic procedures, and an increasing number of specialty clinics and ambulatory centres will further expand the size of cosmetic implants market in the future. The growing influence of social media and the rising awareness among individuals about physical appearance drive the growth of the market in the forecasting period.

As per the analysis, the dental implants segment is anticipated to hold remunerative opportunities for the global cosmetic implants market. Various developing countries are making significant developments in their budgets, thereby, offering lucrative opportunities to players in the market.

Competitive Landscape

Eminent players of the global cosmetic implants market include –

  • 3M Company
  • Polytech Health & Aesthetics GmbH
  • Sientra Inc.
  • GC Aesthetics Plc.
  • Danaher Corporation
  • Dentsply Sirona Inc.
  • Straumann
  • Johnson & Johnson
  • Zimmer Biomet Holdings Inc.
  • AbbVie Inc.
  • Cochlear Ltd.
  • Henry Schein Inc.

Browse More Details@ https://www.futuremarketinsights.com/reports/cosmetic-implants-market

Recent key developments among players include:

  • In January 2022 -- Sientra, Inc. announced the acquisition of all of the assets related to AuraGen Aesthetic, LLC's novel fat grafting technology, the AuraGen with AuraClens. The AuraGen system was developed by leading researchers and plastic surgeons. AuraGen's transformative fat grafting system includes the face, potentially replacing currently available procedures using synthetic fillers with a procedure that uses the patient's own tissue

  • In May 2022, GC Aesthetics®, Inc. announced the launch of an innovative Nipple Areola Complex (NAC). This unrivaled medical device is the answer to a well-known clinical need of thousands of women around the world. Until now, a variety of surgical techniques are used to try to reconstruct the nipple-areola complex with none providing a long-term aesthetic solution.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global church management software market presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.

Key Segments Covered in the Cosmetic Implants Industry Survey

Cosmetic Implants Market by Product Type:

  • Cosmetic Breast Implants
  • Cosmetic Facial Implants
  • Cosmetic Dental Implants
  • Other Cosmetic Implants

Cosmetic Implants Market by Raw Material:

  • Biomaterial implants in Cosmetic Implants
  • Metal implants in Cosmetic Implants
  • Polymers Implants in Cosmetic Implants
  • Ceramic Implant in Cosmetic Implants

Cosmetic Implants Market by Region:

  • North America
  • Europe
  • APAC
  • Middle East & Africa
  • Latin America

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more